BioElectronics Corporation's Chairman Updates Investors
October 16, 2024 08:45 ET
|
BioElectronics Corporation
Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
March 25, 2024 08:45 ET
|
BioElectronics Corporation
96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation...
BioElectronics Corporation Announces the Publication of Pilot Study Results
February 23, 2024 08:30 ET
|
BioElectronics Corporation
Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Chairman Updates Investors
February 15, 2024 09:00 ET
|
BioElectronics Corporation
Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation...
End of Year Message From the Chairman of the Board of BioElectronics
December 22, 2023 15:55 ET
|
BioElectronics Corporation
FREDERICK, MD, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corp. (OTC: BIEL) is pleased to provide this end of year message to investors, customers, suppliers and other...
BioElectronics’ Chairman Discusses Recent Clinical Research Findings
July 22, 2022 06:00 ET
|
BioElectronics Corporation
Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a...
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
April 06, 2022 06:00 ET
|
BioElectronics Corporation
FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that...
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico
March 30, 2022 06:00 ET
|
BioElectronics Corporation
FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has...
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
February 28, 2022 07:00 ET
|
BioElectronics Corporation
FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard...
BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway
January 03, 2022 06:00 ET
|
BioElectronics Corporation
FREDERICK, MD, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC...